We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current VRAX market cap is 1.24M. The company's latest EPS is USD -3.5093 and P/E is -0.23.
| Quarter End | ||||
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | ||||
| Operating Income | ||||
| Net Income |
| Year End March 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 100k | 124k | 0 | 9k |
| Operating Income | -651k | -644k | -1.73M | -5.73M |
| Net Income | -710k | -651k | -1.71M | -5.46M |
| Quarter End | ||||
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | ||||
| Total Liabilities | ||||
| Total Equity |
| Year End March 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 23k | 40k | 49k | 9.81M |
| Total Liabilities | 1.24M | 872k | 1.25M | 908k |
| Total Equity | -1.22M | -832k | -1.2M | 8.9M |
| Market Cap | 1.24M |
| Price to Earnings Ratio | -0.23 |
| Price to Sales Ratio | 137.93 |
| Price to Cash Ratio | 0.13 |
| Price to Book Ratio | 0.14 |
| Dividend Yield | - |
| Shares Outstanding | 1.56M |
| Average Volume (1 week) | 45.77k |
| Average Volume (1 Month) | 25.75k |
| 52 Week Change | -77.20% |
| 52 Week High | 5.445 |
| 52 Week Low | 0.60 |
| Spread (Intraday) | 0.09 (10.43%) |
| Company Name | Virax Biolabs Group Ltd |
| Address |
30 broadwick street london oxon |
| Website | https://viraxbiolabs.com |
| Industry | in vitro,in vivo diagnostics (2835) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
